The future is calling: development & manufacturing of Janssen’s first CAR-T therapy

The future is calling: development & manufacturing of Janssen’s first CAR-T therapy

De opleiding Biomedische Laboratoriumtechnologie (BLT) van de Thomas More Hogeschool organiseert op donderdag 30 maart een gratis avondlezing.

“The future is calling: development & manufacturing of Janssen’s first CAR-T therapy”

During this session we will address the unmet needs of patients living with cancer as we will explore specifically Janssen’s novel therapeutic strategy on CAR-T therapy.

Janssen will produce innovative cell therapies in Belgium for the treatment of certain types of cancer in Europe. Together with Legend Biotech, we are building our first state-of-the-art facilities both in Ghent and Beerse to make the manufacturing of CAR-T cell therapy possible.

Find out more about this innovative journey, the hope it brings for so many patients and the unique opportunities that are created for talent with a passion for biotechnology.  

Wie?

Sprekers: Bie Van de Vloet en An-Sofie Stevens – Janssen Pharmaceutica

Wanneer en waar?

De lezing vindt plaats op 30/03/2023 tussen 19.00 en 20u30 bij Thomas More, Kleinhoefstraat 4 in Geel.

De lezing is gratis maar vooraf inschrijven is noodzakelijk en kan via onderstaande link:

https://forms.office.com/e/XbdTMyDyrh

 

Date

mrt 30 2023
Expired!

Time

19:00 - 20:30

Location

Thomas More Kempen
Category

Organizer

Thomas More